Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (611-620 of 826) with videos related to

Pageof 83
Sort By:
ESC Heart Failure|April 11, 2022
Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure studyCecilia Linde, Mattias Ekström, Maria J Eriksson, et al.
International Journal of Cardiology|May 18, 2023
Identifying distinct clinical clusters in heart failure with mildly reduced ejection fractionClaartje Meijs, Jasper J Brugts, Lars H Lund, et al.
ESC Heart Failure|February 19, 2026
Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fractionEmilia D'Elia, Raul Limonta, Cinzia Giaccherini, et al.
Journal of the American Heart Association|July 21, 2017
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) ProjectGhassan Bandak, Yingying Sang, Alessandro Gasparini, et al.
ESC Heart Failure|October 16, 2021
'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factorAmr Abdin, Stefan D Anker, Javed Butler, et al.
JACC. Cardiovascular Imaging|August 17, 2024
An Automated Machine Learning-Based Quantitative Multiparametric Approach for Mitral Regurgitation Severity GradingAnita Sadeghpour, Zhubo Jiang, Yoran M Hummel, et al.
ESC Heart Failure|November 3, 2023
Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fractionMikael Erhardsson, Ulrika Ljung Faxén, Ashwin Venkateshvaran, et al.
European Journal of Heart Failure|June 16, 2023
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure RegistryNgoc V Nguyen, Felix Lindberg, Lina Benson, et al.
Cell Cycle (Georgetown, Tex.)|March 4, 2011
MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell linesGiuditta Viticchiè, Anna Maria Lena, Alessia Latina, et al.
European Journal of Heart Failure|December 11, 2019
Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillationMarija Polovina, Lars H Lund, Dijana Đikić, et al.
Pageof 83

Showing results (611-620 of 826) with videos related to

Sort By:
Pageof 83
ESC Heart Failure|April 11, 2022
Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure studyCecilia Linde, Mattias Ekström, Maria J Eriksson, et al.
International Journal of Cardiology|May 18, 2023
Identifying distinct clinical clusters in heart failure with mildly reduced ejection fractionClaartje Meijs, Jasper J Brugts, Lars H Lund, et al.
ESC Heart Failure|February 19, 2026
Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fractionEmilia D'Elia, Raul Limonta, Cinzia Giaccherini, et al.
Journal of the American Heart Association|July 21, 2017
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) ProjectGhassan Bandak, Yingying Sang, Alessandro Gasparini, et al.
ESC Heart Failure|October 16, 2021
'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factorAmr Abdin, Stefan D Anker, Javed Butler, et al.
JACC. Cardiovascular Imaging|August 17, 2024
An Automated Machine Learning-Based Quantitative Multiparametric Approach for Mitral Regurgitation Severity GradingAnita Sadeghpour, Zhubo Jiang, Yoran M Hummel, et al.
ESC Heart Failure|November 3, 2023
Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fractionMikael Erhardsson, Ulrika Ljung Faxén, Ashwin Venkateshvaran, et al.
European Journal of Heart Failure|June 16, 2023
Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure RegistryNgoc V Nguyen, Felix Lindberg, Lina Benson, et al.
Cell Cycle (Georgetown, Tex.)|March 4, 2011
MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell linesGiuditta Viticchiè, Anna Maria Lena, Alessia Latina, et al.
European Journal of Heart Failure|December 11, 2019
Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillationMarija Polovina, Lars H Lund, Dijana Đikić, et al.
Pageof 83